Angelique W. Levi, MD

• Adebowale Adeniran
• Darryl T. Martin
• David Rimm
• Guoping Cai
• Jeffrey Weinreb
• John Sinard
• Lawrence Staib
• Malini Harigopal
• Michael S. Leapman
• Pei Hui
• Peter A Humphrey
• Preston C. Sprenkle
• Veronika Shabanova

Uterine Cervical Dysplasia; Pathology; Prognosis; Prostate; Global Health; Cancer Vaccines; Human papillomavirus 16; Early Detection of Cancer; Human Papillomavirus DNA Tests; Atypical Squamous Cells of the Cervix; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; Machine Learning; COVID-19; SARS-CoV-2; COVID-19 Vaccines; COVID-19 Testing

Cancer; Clinical Trials; Emerging Infectious Diseases; Global Health; Sexually-Transmitted Infections; Vaccines; Health Equity, Disparities, Social Determinants and Justice; Implementation Science

• Cytological Evaluation of Upper Urinary Tract Specimens: An Institutional Retrospective Study Using The Paris System for Reporting Urine Cytology Second Edition with Histopathologic Follow UpKhajir G, Sun T, Wang H, Adeniran A, Cai G, Levi A. Cytological Evaluation of Upper Urinary Tract Specimens: An Institutional Retrospective Study Using The Paris System for Reporting Urine Cytology Second Edition with Histopathologic Follow Up. Journal Of The American Society Of Cytopathology 2022, 11: s35. DOI: 10.1016/j.jasc.2022.07.065.
• Cervical Cancer Screening Using Primary High-Risk HPV (hrHPV) Versus Cotesting: Implications for hrHPV-Negative Patients with High Grade Squamous Epithelial LesionManrai P, Levi A, Sun T, Wang M, Cai G, Abi-Raad R. Cervical Cancer Screening Using Primary High-Risk HPV (hrHPV) Versus Cotesting: Implications for hrHPV-Negative Patients with High Grade Squamous Epithelial Lesion. Journal Of The American Society Of Cytopathology 2022, 11: s32. DOI: 10.1016/j.jasc.2022.07.060.
• Prediction of Adverse Pathology at Radical Prostatectomy in Grade Group 2 and 3 Prostate Biopsies Using Machine Learning.Paulson N, Zeevi T, Papademetris M, Leapman MS, Onofrey JA, Sprenkle PC, Humphrey PA, Staib LH, Levi AW. Prediction of Adverse Pathology at Radical Prostatectomy in Grade Group 2 and 3 Prostate Biopsies Using Machine Learning. JCO Clinical Cancer Informatics 2022, 6: e2200016. PMID: 36179281, DOI: 10.1200/cci.22.00016.
• MP45-09 DISCRIMINATIVE SIGNIFICANCE OF PROSTATE BIOPSY DECIPHER SCORE TO PREDICT ADVERSE PATHOLOGY AND PATHOLOGICAL DISCORDANCE AT RADICAL PROSTATECTOMYKhajir G, Kumar D, Rahman S, Leapman M, Levi A, Humphrey P, Sprenkle P. MP45-09 DISCRIMINATIVE SIGNIFICANCE OF PROSTATE BIOPSY DECIPHER SCORE TO PREDICT ADVERSE PATHOLOGY AND PATHOLOGICAL DISCORDANCE AT RADICAL PROSTATECTOMY. Investigative Urology 2022, 207: e765. DOI: 10.1097/ju.0000000000002611.09.
• Distribution of NCCN risk classifications using MRI-ultrasound fusion versus systematic 12 core biopsies.Khajir G, Press B, Levi A, Sprenkle P, Leapman M. Distribution of NCCN risk classifications using MRI-ultrasound fusion versus systematic 12 core biopsies. Journal Of Clinical Oncology 2022, 40: 283-283. DOI: 10.1200/jco.2022.40.6_suppl.283.
• International Multi-Site Initiative to Develop an MRI-Inclusive Nomogram for Side-Specific Prediction of Extraprostatic Extension of Prostate CancerWibmer AG, Kattan MW, Alessandrino F, Baur ADJ, Boesen L, Franco FB, Bonekamp D, Campa R, Cash H, Catalá V, Crouzet S, Dinnoo S, Eastham J, Fennessy FM, Ghabili K, Hohenfellner M, Levi AW, Ji X, Løgager V, Margolis DJ, Moldovan PC, Panebianco V, Penzkofer T, Puech P, Radtke JP, Rouvière O, Schlemmer HP, Sprenkle PC, Tempany CM, Vilanova JC, Weinreb J, Hricak H, Shukla-Dave A. International Multi-Site Initiative to Develop an MRI-Inclusive Nomogram for Side-Specific Prediction of Extraprostatic Extension of Prostate Cancer. Cancers 2021, 13: 2627. PMID: 34071842, PMCID: PMC8198352, DOI: 10.3390/cancers13112627.
• Extent of High-Grade Prostatic Adenocarcinoma in Multiparametric Magnetic Resonance Imaging-Targeted Biopsy Enhances Prediction of Pathologic Stage.Paulson N, Vollmer RT, Humphrey PA, Sprenkle PC, Onofrey J, Huber S, Amirkhiz K, Levi AW. Extent of High-Grade Prostatic Adenocarcinoma in Multiparametric Magnetic Resonance Imaging-Targeted Biopsy Enhances Prediction of Pathologic Stage. Archives Of Pathology & Laboratory Medicine 2021, 146: 201-204. PMID: 34015819, DOI: 10.5858/arpa.2020-0568-oa.
• An independent assessment of an artificial intelligence system for prostate cancer detection shows strong diagnostic accuracyPerincheri S, Levi AW, Celli R, Gershkovich P, Rimm D, Morrow JS, Rothrock B, Raciti P, Klimstra D, Sinard J. An independent assessment of an artificial intelligence system for prostate cancer detection shows strong diagnostic accuracy. Modern Pathology 2021, 34: 1588-1595. PMID: 33782551, PMCID: PMC8295034, DOI: 10.1038/s41379-021-00794-x.
• High-Risk Human Papillomavirus Testing, Genotyping, and Histopathologic Follow-up in Women With Abnormal Glandular Cells on Papanicolaou Tests.Zuo T, Levi AW, Lin Q, Abi-Raad R, Adeniran AJ, Cai G. High-Risk Human Papillomavirus Testing, Genotyping, and Histopathologic Follow-up in Women With Abnormal Glandular Cells on Papanicolaou Tests. American Journal Of Clinical Pathology 2021, 156: 569-576. PMID: 33728437, DOI: 10.1093/ajcp/aqaa265.
• Doubling of Decipher Biopsy Genomic Score Is Related to Disease Reclassification on Subsequent Surveillance Biopsy but Not Adverse Features on Radical ProstatectomyGhabili K, Paulson N, Syed JS, Nawaf CB, Khajir G, Martin DT, Onofrey J, Leapman MS, Levi A, Weinreb JC, Humphrey PA, Sprenkle PC. Doubling of Decipher Biopsy Genomic Score Is Related to Disease Reclassification on Subsequent Surveillance Biopsy but Not Adverse Features on Radical Prostatectomy. Case Reports In Urology 2021, 2021: 2687416. PMID: 33936831, PMCID: PMC8054861, DOI: 10.1155/2021/2687416.
• Measuring Faculty Effort: A Quantitative Approach That Aligns Personal and Institutional Goals in Pathology at YaleMorrow JS, Gershkovich P, Gibson J, Gilshannon M, Kowalski D, Levi AW, Nguyen DX, Rimm DL, Xu ML, Sinard J. Measuring Faculty Effort: A Quantitative Approach That Aligns Personal and Institutional Goals in Pathology at Yale. Academic Pathology 2021, 8: 23742895211047985. PMID: 34646939, PMCID: PMC8504692, DOI: 10.1177/23742895211047985.
• Fine needle aspiration cytology of a neck massGilani SM, Levi A. Fine needle aspiration cytology of a neck mass. Cytopathology 2020, 31: 622-623. PMID: 32569432, DOI: 10.1111/cyt.12878.
• MP23-11 PREDICTION OF ADVERSE OUTCOMES AT RADICAL PROSTATECTOMY IN GRADE GROUP 2 AND 3 PROSTATE BIOPSIES USING MACHINE LEARNINGPaulson* N, Zeevi T, Papademetris M, Onofrey J, Sprenkle P, Humphrey P, Staib L, Levi A. MP23-11 PREDICTION OF ADVERSE OUTCOMES AT RADICAL PROSTATECTOMY IN GRADE GROUP 2 AND 3 PROSTATE BIOPSIES USING MACHINE LEARNING. Investigative Urology 2020, 203 DOI: 10.1097/ju.0000000000000856.011.
• Clinical Implications of "Atypical Glandular Cells" in Cervical Cytologic SpecimensManrai P, Yoon E, Raad R, Levi A, Harigopal M. Clinical Implications of "Atypical Glandular Cells" in Cervical Cytologic Specimens. Journal Of The American Society Of Cytopathology 2019, 8: s28-s29. DOI: 10.1016/j.jasc.2019.08.068.
• Economics, Regulations, and Trends in PracticeLevi A, Cai G. Economics, Regulations, and Trends in Practice. 2019, 407-412. DOI: 10.1007/978-3-030-21799-0_15.
• PD11-11 DECIPHER BIOPSY GENOMIC TEST RELATED TO GLEASON GRADE GROUP INDEPENDENT OF PROSTATE IMAGING REPORTING AND DATA SYSTEM VERSION 2Martin D, Ghabili* K, Levi A, Humphrey P, Schulam P, Sprenkle P. PD11-11 DECIPHER BIOPSY GENOMIC TEST RELATED TO GLEASON GRADE GROUP INDEPENDENT OF PROSTATE IMAGING REPORTING AND DATA SYSTEM VERSION 2. Investigative Urology 2019, 201 DOI: 10.1097/01.ju.0000555367.28091.c8.
• Prostate Cancer Genomic Classifier Relates More Strongly to Gleason Grade Group Than Prostate Imaging Reporting and Data System Score in Multiparametric Prostate Magnetic Resonance Imaging-ultrasound Fusion Targeted BiopsiesMartin DT, Ghabili K, Levi A, Humphrey PA, Sprenkle PC. Prostate Cancer Genomic Classifier Relates More Strongly to Gleason Grade Group Than Prostate Imaging Reporting and Data System Score in Multiparametric Prostate Magnetic Resonance Imaging-ultrasound Fusion Targeted Biopsies. Urology 2018, 125: 64-72. PMID: 30552940, DOI: 10.1016/j.urology.2018.12.001.
• Prostate zonal anatomy correlates with the detection of prostate cancer on multiparametric magnetic resonance imaging/ultrasound fusion–targeted biopsy in patients with a solitary PI-RADS v2–scored lesionSyed JS, Nguyen KA, Nawaf CB, Bhagat AM, Huber S, Levi A, Humphrey P, Weinreb JC, Schulam PG, Sprenkle PC. Prostate zonal anatomy correlates with the detection of prostate cancer on multiparametric magnetic resonance imaging/ultrasound fusion–targeted biopsy in patients with a solitary PI-RADS v2–scored lesion. Urologic Oncology Seminars And Original Investigations 2017, 35: 542.e19-542.e24. PMID: 28501565, DOI: 10.1016/j.urolonc.2017.04.011.
• Negative Multiparametric Magnetic Resonance Imaging of the Prostate Predicts Absence of Clinically Significant Prostate Cancer on 12-Core Template Prostate BiopsyLu AJ, Syed JS, Nguyen KA, Nawaf CB, Rosoff J, Spektor M, Levi A, Humphrey PA, Weinreb JC, Schulam PG, Sprenkle PC. Negative Multiparametric Magnetic Resonance Imaging of the Prostate Predicts Absence of Clinically Significant Prostate Cancer on 12-Core Template Prostate Biopsy. Urology 2017, 105: 118-122. PMID: 28322902, DOI: 10.1016/j.urology.2017.01.048.
• The positive predictive value of PI-RADS 4 lesions stratified by lesion number in biopsy naïve men.Syed J, Javier-desloges J, Nguyen K, Sheridan A, Levi A, Weinreb J, Sprenkle P. The positive predictive value of PI-RADS 4 lesions stratified by lesion number in biopsy naïve men. Journal Of Clinical Oncology 2017, 35: 29-29. DOI: 10.1200/jco.2017.35.6_suppl.29.
• PD15-11 SHOULD WE STILL BIOPSY NEGATIVE MP-MRIS?Lu A, Nawaf C, Rosoff J, Weinreb J, Humphrey P, Levi A, Huber S, Sprenkle P. PD15-11 SHOULD WE STILL BIOPSY NEGATIVE MP-MRIS? Investigative Urology 2016, 195: e393. DOI: 10.1016/j.juro.2016.02.1137.
• MP15-17 MP-MRI UPGRADES MEN WHO HAVE HAD A BIOPSY SHOWING PRIOR CANCERNawaf C, Rosoff J, Weinreb J, Humphrey P, Levi A, Huber S, Sprenkle P. MP15-17 MP-MRI UPGRADES MEN WHO HAVE HAD A BIOPSY SHOWING PRIOR CANCER. Investigative Urology 2016, 195: e158. DOI: 10.1016/j.juro.2016.02.2541.
• A Comparison of the Roche Cobas HPV Test With the Hybrid Capture 2 Test for the Detection of High-Risk Human Papillomavirus GenotypesLevi AW, Bernstein JI, Hui P, Duch K, Schofield K, Chhieng DC. A Comparison of the Roche Cobas HPV Test With the Hybrid Capture 2 Test for the Detection of High-Risk Human Papillomavirus Genotypes. Archives Of Pathology & Laboratory Medicine 2016, 140: 153-7. PMID: 26910220, DOI: 10.5858/arpa.2015-0027-oa.
• MRI-US fusion targeted biopsy results in patients without history of prostate biopsy.Nawaf C, Rosoff J, Weinreb J, Lu A, Levi A, Humphrey P, Schulam P, Sprenkle P. MRI-US fusion targeted biopsy results in patients without history of prostate biopsy. Journal Of Clinical Oncology 2016, 34: 150-150. DOI: 10.1200/jco.2016.34.2_suppl.150.
• MRI-US fusion targeted biopsy results in men with a history of prior cancer.Nawaf C, Rosoff J, Lu A, Weinreb J, Humphrey P, Levi A, Schulam P, Sprenkle P. MRI-US fusion targeted biopsy results in men with a history of prior cancer. Journal Of Clinical Oncology 2016, 34: 88-88. DOI: 10.1200/jco.2016.34.2_suppl.88.
• MRI-US fusion targeted biopsy results in patients with a history of a prior negative biopsy.Nawaf C, Lu A, Rosoff J, Weinreb J, Schulam P, Humphrey P, Levi A, Sprenkle P. MRI-US fusion targeted biopsy results in patients with a history of a prior negative biopsy. Journal Of Clinical Oncology 2016, 34: 90-90. DOI: 10.1200/jco.2016.34.2_suppl.90.
• Prostate cancer detection rates of negative MP-MRIs.Lu A, Nawaf C, Weinreb J, Rosoff J, Schulam P, Humphrey P, Levi A, Sprenkle P. Prostate cancer detection rates of negative MP-MRIs. Journal Of Clinical Oncology 2016, 34: 91-91. DOI: 10.1200/jco.2016.34.2_suppl.91.
• Detection and Genotype of High-Risk Human Papillomavirus in Fine-Needle Aspirates of Patients With Metastatic Squamous Cell Carcinoma Is Helpful in Determining Tumor OriginBaldassarri R, Aronberg R, Levi AW, Yarbrough WG, Kowalski D, Chhieng D. Detection and Genotype of High-Risk Human Papillomavirus in Fine-Needle Aspirates of Patients With Metastatic Squamous Cell Carcinoma Is Helpful in Determining Tumor Origin. American Journal Of Clinical Pathology 2015, 143: 694-700. PMID: 25873503, DOI: 10.1309/ajcpcza4pszcfhq4.
• What Would We Miss if HR-HPV Testing Was Used for Primary Cervical Cancer ScreeningBernstein J, Chhieng D, Levi A. What Would We Miss if HR-HPV Testing Was Used for Primary Cervical Cancer Screening. Journal Of The American Society Of Cytopathology 2014, 3: s37. DOI: 10.1016/j.jasc.2014.09.079.
• Human Papillomavirus Testing Using Hybrid Capture II and Cobas 4800 with ThinPrep and SurePath Preparations in Gynecologic CytologySnir O, Baldassarri R, Levi A, Schofield K, Kowalski D, Chhieng D. Human Papillomavirus Testing Using Hybrid Capture II and Cobas 4800 with ThinPrep and SurePath Preparations in Gynecologic Cytology. Journal Of The American Society Of Cytopathology 2014, 3: s43. DOI: 10.1016/j.jasc.2014.09.095.
• Detection and Genotype of High Risk Human Papillomavirus in Fine Needle Aspirates of Patients with Metastatic Squamous Cell Carcinoma is Helpful in Determining Tumor OriginWong R, Aronberg R, Levi A, Yarbrough W, Kowalski D, Chhieng D. Detection and Genotype of High Risk Human Papillomavirus in Fine Needle Aspirates of Patients with Metastatic Squamous Cell Carcinoma is Helpful in Determining Tumor Origin. Journal Of The American Society Of Cytopathology 2014, 3: s49-s50. DOI: 10.1016/j.jasc.2014.09.109.
• Methylation of Twelve CpGs in Human Papillomavirus Type 16 (HPV16) as an Informative Biomarker for the Triage of Women Positive for HPV16 InfectionBrandsma JL, Harigopal M, Kiviat NB, Sun Y, Deng Y, Zelterman D, Lizardi PM, Shabanova VS, Levi A, Yaping T, Hu X, Feng Q. Methylation of Twelve CpGs in Human Papillomavirus Type 16 (HPV16) as an Informative Biomarker for the Triage of Women Positive for HPV16 Infection. Cancer Prevention Research 2014, 7: 526-533. PMID: 24556390, DOI: 10.1158/1940-6207.capr-13-0354.
• Prior High-Risk Human Papillomavirus Testing and Papanicolaou Test Results of 70 Invasive Cervical Carcinomas Diagnosed in 2012: Results of a Retrospective Multicenter StudyZhao C, Li Z, Nayar R, Levi AW, Winkler BA, Moriarty AT, Barkan GA, Rao J, Miller F, Fan F, Zhou Z, Si Q, Fischer AH, Sturgis CD, Jing X, Marshall CB, Witt BL, Birdsong GG, Crothers BA. Prior High-Risk Human Papillomavirus Testing and Papanicolaou Test Results of 70 Invasive Cervical Carcinomas Diagnosed in 2012: Results of a Retrospective Multicenter Study. Archives Of Pathology & Laboratory Medicine 2014, 139: 184-8. PMID: 24694342, DOI: 10.5858/arpa.2014-0028-oa.
• High-risk HPV Testing in the Detection of Cervical Carcinoma using Liquid-based PreparationsLevi A, Schofield K, Harigopal M, Chhieng D. High-risk HPV Testing in the Detection of Cervical Carcinoma using Liquid-based Preparations. Journal Of The American Society Of Cytopathology 2013, 2: s33. DOI: 10.1016/j.jasc.2013.08.090.
• HPV16 DNA Methylation Analysis for Improved Triage of Atypical Squamous Cell of Undetermined Significance (ASCUS)Harigopal M, Sun Y, Chen X, Levi A, Brandsma J. HPV16 DNA Methylation Analysis for Improved Triage of Atypical Squamous Cell of Undetermined Significance (ASCUS). Journal Of The American Society Of Cytopathology 2013, 2: s45. DOI: 10.1016/j.jasc.2013.08.121.
• Prior High-Risk HPV Testing and Pap Test Results of 58 Invasive Cervical Carcinomas Diagnosed in 2012Zhao C, Nayar R, Levi A, Winkler B, Moriarty A, Barkan G, Li Z, Rao J, Miller F, Fan F, Si Q, Fischer A, Sturgis C, Jing X, Marshall C, Witt B, Crothers B. Prior High-Risk HPV Testing and Pap Test Results of 58 Invasive Cervical Carcinomas Diagnosed in 2012. Journal Of The American Society Of Cytopathology 2013, 2: s3-s4. DOI: 10.1016/j.jasc.2013.08.004.
• Increasing Cytotechnologist Workload Above 100 Slides per Day Using the BD FocalPoint GS Imaging System Negatively Affects Screening PerformanceLevi AW, Galullo P, Gordy K, Mikolaiski N, Schofield K, Elsheikh TM, Harigopal M, Chhieng DC. Increasing Cytotechnologist Workload Above 100 Slides per Day Using the BD FocalPoint GS Imaging System Negatively Affects Screening Performance. American Journal Of Clinical Pathology 2012, 138: 811-815. PMID: 23161714, DOI: 10.1309/ajcptydd9g2ncumf.
• Effectiveness of the FocalPoint GS Imaging System in the Detection of Adenocarcinoma of the Gynecologic SystemWong R, Schofield K, Harigopal M, Ratner E, Chhieng D, Levi A. Effectiveness of the FocalPoint GS Imaging System in the Detection of Adenocarcinoma of the Gynecologic System. Journal Of The American Society Of Cytopathology 2012, 1: s34. DOI: 10.1016/j.jasc.2012.08.072.
• Accuracy of FocalPoint GS Imaging: Can We Trust the System?Honarpisheh H, Schofield K, Harigopal M, Chhieng D, Levi A. Accuracy of FocalPoint GS Imaging: Can We Trust the System? Journal Of The American Society Of Cytopathology 2012, 1: s47. DOI: 10.1016/j.jasc.2012.08.103.
• Value of 3q26 Gain in the Triage of Low-grade Squamous AbnormalitiesAbiraad R, Schofield K, Harigopal M, Chhieng D, Levi A. Value of 3q26 Gain in the Triage of Low-grade Squamous Abnormalities. Journal Of The American Society Of Cytopathology 2012, 1: s46. DOI: 10.1016/j.jasc.2012.08.101.
• Comparing Two Methods of Detection for Chlamydia trachomatis in Liquid-Based Papanicolaou TestsLevi AW, Beckman D, Hui P, Schofield K, Harigopal M, Chhieng DC. Comparing Two Methods of Detection for Chlamydia trachomatis in Liquid-Based Papanicolaou Tests. American Journal Of Clinical Pathology 2012, 138: 236-240. PMID: 22904135, DOI: 10.1309/ajcp2b7xqtcnamjp.
• The Positive Impact of Simultaneous Implementation of the BD FocalPoint GS Imaging System and Lean Principles on the Operation of Gynecologic CytologyWong R, Levi AW, Harigopal M, Schofield K, Chhieng DC. The Positive Impact of Simultaneous Implementation of the BD FocalPoint GS Imaging System and Lean Principles on the Operation of Gynecologic Cytology. Archives Of Pathology & Laboratory Medicine 2012, 136: 183-9. PMID: 22288966, DOI: 10.5858/arpa.2011-0139-oa.
• Implementation of FocalPoint GS location‐guided imaging systemLevi AW, Chhieng DC, Schofield K, Kowalski D, Harigopal M. Implementation of FocalPoint GS location‐guided imaging system. Cancer Cytopathology 2011, 120: 126-133. PMID: 22505211, DOI: 10.1002/cncy.20187.
• Use of high‐risk human papillomavirus testing in patients with low‐grade squamous intraepithelial lesionsLevi AW, Harigopal M, Hui P, Schofield K, Chhieng DC. Use of high‐risk human papillomavirus testing in patients with low‐grade squamous intraepithelial lesions. Cancer Cytopathology 2011, 119: 228-234. PMID: 21732551, DOI: 10.1002/cncy.20172.
• Comparison of Affirm VPIII and Papanicolaou Tests in the Detection of Infectious VaginitisLevi AW, Harigopal M, Hui P, Schofield K, Chhieng DC. Comparison of Affirm VPIII and Papanicolaou Tests in the Detection of Infectious Vaginitis. American Journal Of Clinical Pathology 2011, 135: 442-447. PMID: 21350100, DOI: 10.1309/ajcp7tbn5vzuglzu.
• Prenatal diagnosis of an umbilical vein aneurysm: a case report.Panda B, Stiller R, Iruretagoyena I, Levi A. Prenatal diagnosis of an umbilical vein aneurysm: a case report. Connecticut Medicine 2009, 73: 465-7. PMID: 19777980.
• Urinary Bladder Biopsy With Denuded Mucosa: Denuding Cystitis-Cytopathologic CorrelatesParwani A, Levi A, Epstein J, Ali S. Urinary Bladder Biopsy With Denuded Mucosa: Denuding Cystitis-Cytopathologic Correlates. Investigative Urology 2006, 175: 572. DOI: 10.1016/s0022-5347(05)00191-6.
• Urinary bladder biopsy with denuded mucosa: Denuding cystitis—Cytopathologic correlatesParwani AV, Levi AW, Epstein JI, Ali SZ. Urinary bladder biopsy with denuded mucosa: Denuding cystitis—Cytopathologic correlates. Diagnostic Cytopathology 2004, 30: 297-300. PMID: 15108225, DOI: 10.1002/dc.10406.
• Atypical squamous cells of undetermined significance in liquid‐based cytologic specimensLevi AW, Kelly DP, Rosenthal DL, Ronnett BM. Atypical squamous cells of undetermined significance in liquid‐based cytologic specimens. Cancer 2003, 99: 191-197. PMID: 12925979, DOI: 10.1002/cncr.11507.
• Mollaret's meningitis: Cytopathologic analysis of fourteen casesChan TY, Parwani AV, Levi AW, Ali SZ. Mollaret's meningitis: Cytopathologic analysis of fourteen cases. Diagnostic Cytopathology 2003, 28: 227-231. PMID: 12722116, DOI: 10.1002/dc.10261.
• The pigmented “black” neuroendocrine tumor of the pancreasSehdev A, Levi A, Nadasdy T, Campbell K, Fishman E, Hruban R. The pigmented “black” neuroendocrine tumor of the pancreas. Cancer 2001, 92: 1984-1991. PMID: 11745274, DOI: 10.1002/1097-0142(20011001)92:7<1984::aid-cncr1718>3.0.co;2-0.
• CLINICAL SIGNIFICANCE OF DENUDED UROTHELIUM IN BLADDER BIOPSYLEVI A, POTTER S, SCHOENBERG M, EPSTEIN J. CLINICAL SIGNIFICANCE OF DENUDED UROTHELIUM IN BLADDER BIOPSY. Investigative Urology 2001, 166: 457-460. PMID: 11458047, DOI: 10.1016/s0022-5347(05)65963-0.
• CLINICAL SIGNIFICANCE OF DENUDED UROTHELIUM IN BLADDER BIOPSYLEVI A, POTTER S, SCHOENBERG M, EPSTEIN J. CLINICAL SIGNIFICANCE OF DENUDED UROTHELIUM IN BLADDER BIOPSY. Investigative Urology 2001, 166: 457-460. DOI: 10.1097/00005392-200108000-00013.
• Coexistent Choriocarcinoma and Malignant Mixed Mesodermal Tumor of the UterusNguyen C, Levi A, Montz F, Bristow R. Coexistent Choriocarcinoma and Malignant Mixed Mesodermal Tumor of the Uterus. Gynecologic Oncology 2000, 79: 499-503. PMID: 11104628, DOI: 10.1006/gyno.2000.5976.
• Pseudohyperplastic Prostatic Adenocarcinoma on Needle Biopsy and Simple ProstatectomyLevi A, Epstein J. Pseudohyperplastic Prostatic Adenocarcinoma on Needle Biopsy and Simple Prostatectomy. The American Journal Of Surgical Pathology 2000, 24: 1039-1046. PMID: 10935644, DOI: 10.1097/00000478-200008000-00001.
• The expanding clinical spectrum of desmoplastic small round-cell tumor: a report of two cases with molecular confirmation.Wolf AN, Ladanyi M, Paull G, Blaugrund JE, Westra WH. The expanding clinical spectrum of desmoplastic small round-cell tumor: a report of two cases with molecular confirmation. Hum Pathol 1999, 30: 430-5. PMID: 10208465, DOI: 10.1016/s0046-8177(99)90119-3.